Nachrichten zur GETINGE AB B FR. SK-,50 Aktie

Embracing Getinge’s purpose

Meet Alisa Stafford, an Office Administrator at Getinge who recently took on a new challenge by stepping in front of…

NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)

The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting…

Getinge AB (GNGBF) Q4 2024 Earnings Call Transcript

…

Getinge shares surge on strong Q4, beats expectations across the board By Investing.com

Getinge shares surge on strong Q4, beats expectations across the board…

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

“In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and…

Getinge invites fund managers, analysts, and media to Year-End Report 2024 conference call

Getinge will issue its Year-End Report 2024 on January 28, 2025, at 08:00 a.m. CET, followed by a conference call…

Getinge to be Cincinnati Children’s Anesthesia Fleet Provider

Getinge announced that the first installation of Flow Anesthesia machines has been completed at Cincinnati Children’s hospital. [image] Cincinnati Children’s in Ohio…

Healthmark – a legacy of innovation in infection control

Beginning as a family business to becoming a leader in infection control consumables, Healthmark’s journey is filled with passion, innovation,…

Chenille steps into the spotlight in Getinge’s 2024 company video

Chenille Perry, a Complaints Analyst at Getinge, recently stepped out of her comfort zone to participate in Getinge’s 2024 company…

Full Getinge Surgical Workflows Portfolio Installed at UT Health San Antonio

Today, Getinge announced the first installation of its full Surgical Workflows portfolio in North America at UT Health San Antonio…

Down Over 60%, Is TransMedics Stock a Buy on the Dip?

TransMedics Group (NASDAQ: TMDX) was a top-performing stock that more than doubled in value during the months between the end…

Getinge partnership results in state-of-the-art multi-modality hybrid operating rooms in Italy

Getinge has been part of creating two new multi-modality Hybrid operating rooms (OR) in the ASST Sette Laghi hospital in…

Getinge opens new Experience Center in India

Getinge is opening a new Experience Center in Mumbai, India. The facility recreates real-world healthcare settings to bring customers and…

Changes of the Nomination Committee of Getinge

The composition of Getinge AB (publ)’s Nomination Committee ahead of the 2025 Annual General Meeting has been updated following changed…

Navigating the transforming world of medtech

Meet Salah Malek, Getinge’s Sales President in the Middle East & Africa, who thrives in the dynamic nature of his…

Getinge Announces Official Cybersecurity Clearance From the US Defense Health Agency for Servo Ventilators

As of earlier this year, under the clearance and Authority to Operate (ATO) certification from the US Defense Health Agency…

Contributing to a legacy of life-saving technology

Meet Carl Famulare, a technical associate and long-time member of the Getinge family who recently participated in Getinge’s 2024 company…

Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system

Paragonix Technologies, a leading organ preservation company recently acquired by Getinge, receives FDA clearance for the innovative transportable perfusion device…

Getinge AB (GNGBF) Q3 2024 Earnings Call Transcript

…

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

“The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance,” says Mattias…

FleetView by Getinge elevates service with connected devices

Building on over 15 years of experience in connected devices, Getinge now introduces FleetView. This web application represents the next…

Polyglycerol Ester Surfactants Market is projected to grow from USD 6.95 billion in 2024 to USD 10.24 billion by 2030 | Exactitude Consultancy

Key companies in the global market include Lonza, Dupont, Clariant, Evonik, Croda, BASF, ABITEC, Mitsubishi Chemical, Sakamoto Yakuhin Kogyo, Riken…

Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Getinge will issue its Q3 Report 2024 on October 18, 2024, at 08:00 a.m. CEST, followed by a conference call…

Getinge’s CE certificate for ECLS consumables reinstated

The notified body, TÜV SÜD, reinstates Getinge’s CE certificate for HLS and PLS consumables, used for ECLS therapy, with certain…

Getinge partners with MEDITECH on Talis Clinical solutions to enhance anesthesia management

In response to the growing demands on healthcare systems, Getinge’s Talis Clinical, a leader in anesthesia management solutions, has joined…

Getinge completes the acquisition of Paragonix Technologies

Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc. [image] On August 22, 2024,…

Global Hospital Acquired Infection Control Market Size To Worth USD 5.8 Billion by 2033 | CAGR of 3.53%

The Global Hospital Acquired Infection Control Market Size was Valued at USD 4.1 Billion in 2023 and the Worldwide Hospital…

Getinge makes a provision of MBRL 240 related to Brazilian investigation

Getinge makes a provision of MBRL 240, corresponding to approximately MSEK 480, related to the previously announced negotiations with the Brazilian…

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Today, Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company…

Getinge Enters Strategic Sales Partnership with SurgicalOne

Today, Getinge USA Sales, LLC and SurgicalOne, Inc. announced a new strategic distribution partnership in the promotion of autofluorescence and…

Getinge AB (GNGBF) Q2 2024 Earnings Call Transcript

…

Getinge AB (publ) reports Q2 results

…

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

“Net sales increased by 15.7% in the second quarter, of which the organic increase was 8.9%,” says Mattias Perjos, President…

Digitalization partnership streamlines sterile workflow in Japan

A renowned third-party sterilization service provider in Japan, medical bear, has forged a strategic partnership with Getinge in a transformation…

Should Weakness in Getinge AB (publ)s (STO:GETI B) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

With its stock down 10% over the past three months, it is easy to disregard Getinge (STO:GETI B). But if…

Getinge extends and elevates partnership with Universeum

Getinge announces the extension and elevation of its partnership with Universeum, Swedens national science center. This renewed commitment underscores Getinges…

Getinge launches Pulsiocare – the next generation in hemodynamic monitoring

Getinge announces the launch of Pulsiocare, an advanced hemodynamic monitoring platform that recently received its CE certificate. The state-of-the-art device…

Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call

Getinge will issue its Q2 Report 2024 on July 18, 2024, at 08:00 a.m. CEST, followed by a conference call…

Continuous ways to improve and innovate

Peta Ryan, Principal Analytical Development Chemist at Getinge, shares insights into her dynamic role at the Getinge’s Center for Excellence…

Father and son duo share a quarter-century journey at Getinge

In the heart of Getinge’s Merrimack production site in New Hampshire, a beautiful story unfolds where Jason and Frank Smith,…

Getinge receives U.S. FDA 510(k) clearance for Talis +ACG Clinical Decision Support software, pioneering quality of high-acuity care in US and EU

Getinge has been granted U.S. FDA 510(k) clearance for its innovative clinical decision support software Talis +ACG (Advanced Clinical Guidance),…

Getinge erhält 510(k)-Zulassung der FDA für die Talis +ACG-Software zur Unterstützung klinischer Entscheidungen

Getinge hat die 510(k)-Zulassung der amerikanischen Gesundheitsbehörde FDA für seine innovative klinische Entscheidungsunterstützungssoftware Talis +ACG (Advanced Clinical Guidance) erhalten, die…

Getinge Announces U.S. Launch of XEN Cleaning Chemistries to Enhance Safety and Efficiency in Sterile Processing Departments

Today Getinge announced the launch of XEN, a new and improved range of cleaning chemistries designed to optimize equipment performance,…

dpa-AFX ProFeed